Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Sam Bose receives his poster prize at the BHF CRE event on 3 October

Congratulations to Dr Sam Bose, from the Burton lab, who won the Best Poster Prize in the postdoc category at this week's BHF CRE Annual Symposium 2019.

Sam presented his poster titled 'IP3 mediated changes in guinea pig SA node beating rate are dependent upon Ca2+-sensitive adenylyl cyclases and independent of soluble guanylyl cyclase activity'. A record 60 posters were submitted for this year's event.

The Oxford BHF CRE annual research symposium creates an opportunity for cardiovascular researchers from across the basic, clinical and population sciences to meet and share ideas and opportunities for research and collaborations.

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.